Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Loss of consciousness; myocardial infarction; This is a spontaneous report from a contactable health care professional. A 52-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EK4238, expiry date unknown), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Medical history included Barrett esophagus, morbidly obese (BI-58) and asthma all from an unknown date. The patient''s concomitant medications were not reported. It was reported that the circumstances of death loss of consciousness at home and myocardial infarction on an unspecified date (reported time frame was 6 days). The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected; Sender''s Comments: Based on the information provided, the reported events are likely intercurrent medical condition and unrelated to BNT162B2. Case will be reassess once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Loss of consciousness; myocardial infarction
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166